Delta Expands Global Breast Cancer Research Support, Surpasses $36m Commitment
Delta Air Lines has expanded its long-running partnership with the Breast Cancer Research Foundation (BCRF), announcing a new global funding initiative as it marks 21 years of supporting research into breast cancer.
The airline said its partnership with BCRF has helped fund more than 720,000 hours of breast cancer research since 2005, with its overall financial commitment now exceeding $36 million.
The latest initiative, known as The Delta Air Lines Fund in Support of Global Breast Cancer Research, is designed to broaden access to research funding by bringing donations made through Delta’s Team Delta donation platform together under a single fund.
According to Delta, the new approach will enable scientists around the world to pursue research funding while encouraging greater collaboration and data-driven discoveries across borders.
“For so many of us, breast cancer is personal,” said Kristen Manion Taylor, Delta’s Senior Vice President of Brand Experience.
“We’ve fought it, stood beside loved ones through it and seen what’s possible when the Delta community comes together. As we look ahead, we’re proud to deepen our support of BCRF and continue finding new ways to make a difference.”
Delta said the expanded commitment comes as breast cancer remains a major health challenge in the United States, with BCRF estimating that 324,580 people will be diagnosed with the disease in 2026.
The airline said its partnership with BCRF has contributed to research aimed at improving understanding, detection and treatment of breast cancer.
One example highlighted by the organisations is the OPTIMA trial, which investigated whether some patients with high-risk breast cancer could safely avoid chemotherapy.
The trial builds on a genomic test developed through research supported by BCRF. The research is intended to advance a more personalised approach to treatment by helping doctors determine which patients are more likely to benefit from chemotherapy.
Delta said the development illustrates the role sustained research funding can play in moving discoveries from the laboratory into clinical decision-making.
BCRF President and Chief Executive Officer Donna McKay said research remained central to improving outcomes for people diagnosed with breast cancer.
“Research is what moves us closer to a future where more people can live longer, healthier lives after a breast cancer diagnosis,” McKay said.
“Delta has helped make that progress possible, and we’re excited to build on that momentum together by creating new opportunities for researchers around the world.”
Delta is also marking 15 years of its Breast Cancer One (BC1) Charter, an initiative that brings together employees whose lives have been affected by breast cancer.
The 2026 charter is scheduled to operate from October 7 to 9, flying from Atlanta to Las Vegas. The programme includes a welcome celebration, discussions with BCRF researchers and a private F1 Arcade experience.
Creator and breast cancer survivor Bridget Bahl will join this year’s group to share her experience and promote awareness, early detection, community support and research.
“You don’t get to choose every chapter of your story, but you do get to choose what you do with it,” Bahl said. “I’m grateful for opportunities like this partnership with Delta and the Breast Cancer Research Foundation that allow me to turn something incredibly difficult into a chance to connect with people, raise awareness and hopefully make someone else feel a little less alone.”
Beyond the charter, Delta said it was providing employees with additional opportunities to focus on prevention and access support.
The airline said in-network mammograms are covered at no additional cost through its medical plans, while mobile mammography appointments are available at Delta-specific locations in Atlanta and Minneapolis.
Employees affected by cancer can also access support through Hope Thrives, Delta’s cancer support group.
As Breast Cancer Awareness Month gets under way in October, Delta is also taking its campaign to passengers and airport facilities.
The airline recently joined BCRF and other partners at Vanderbilt Hall in New York’s Grand Central Terminal for an interactive awareness event focused on breast cancer prevention, life after diagnosis, research and ways of supporting the cause.
Throughout October, Delta customers will have several opportunities to contribute.
On board its aircraft, 25 per cent of onboard purchases and 100 per cent of Pink Drink sales will benefit BCRF.
This year’s pink-themed drinks include the new Pink Cran Fizz and Pink Ribbon Sparkler, alongside returning options such as Minute Maid Pink Lemonade and Une Femme “The Callie” Sparkling Rosé.
Passengers can also use Delta Sync seatback entertainment to explore a specially curated collection about the people, research and scientific discoveries involved in the fight against breast cancer.
Participating Delta Sky Clubs and Delta One Lounges will also feature pink-themed activities and additional opportunities for customers to support the campaign.
Customers can make direct donations to BCRF through Delta’s campaign platform, while SkyMiles members can donate miles through Delta’s SkyWish programme.
Delta said the expanded initiative reflects its intention to make its long-standing partnership with BCRF more accessible to both customers and employees.
After more than two decades of collaboration, the airline said the central objective remains unchanged: supporting research and initiatives aimed at making a future without breast cancer possible.
